ACADIA Pharmaceuticals(ACAD) - 2024 Q3 - Earnings Call Transcript

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q3 2024 Earnings Conference Call November 6, 2024 4:30 PM ET Company Participants Al Kildani - SVP, IR and Corporate Communications Catherine Owen-Adams - CEO Brendan Teehan - COO, Head of Commercial Liz Thompson - EVP, Head of Research and Development Mark Schneyer - CFO Conference Call Participants Gregory Renza - RBC Capital Markets Jason Butler - Citizens JMP Joe Beatty - Baird Keith Tapper - BMO Capital Markets Tazeen Ahmad - Bank of America Jeff Hung - Morgan ...